Active Ingredient: CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Proprietary Name: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 16MG;12.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090704
Product Number: 001
Approval Date: Dec 4, 2012
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Proprietary Name: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 32MG;12.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090704
Product Number: 002
Approval Date: Dec 4, 2012
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Proprietary Name: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 32MG;25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090704
Product Number: 003
Approval Date: Dec 4, 2012
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information